Zhejiang CONBA Pharmaceutical Co.,Ltd.
SHH: 600572.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Guoliang Luo
- Employees
- 8,411
- Headquarters
- Hangzhou, China
- IPO year
- 2004
- Market cap
- CN¥11.2B
- Website
- https://www.conbagroup.com
Loading 600572…
Loading profile data…Frequently asked questions about 600572
What does Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) do?
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other person...
Where does 600572.SS trade?
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) trades on the Shanghai Stock Exchange.
What sector is 600572.SS in?
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Zhejiang CONBA Pharmaceutical Co.,Ltd.?
Guoliang Luo is the chief executive officer of Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS).
Where is Zhejiang CONBA Pharmaceutical Co.,Ltd. headquartered?
Zhejiang CONBA Pharmaceutical Co.,Ltd. is headquartered in China.
Does 600572.SS pay a dividend?
Yes — Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) paid a trailing twelve-month dividend of CNY 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600572.SS go public?
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS) completed its initial public offering in 2004.